UPC Analytics
ENDE
Overview · Filed: Jun 10, 2025

UPC_CFI_497/2025

A CELL MEDIATED IMMUNE RESPONSE ASSAY WITH ENHANCED SENSITIVITY

Parent infringement case:UPC_CFI_181/2025

RevocationCounter Claim for RevocationDusseldorf LDCounter claim for revocationWritten Phase
Parties

Claimants

  • bioMérieux Deutschland GmbH

Respondents

  • QIAGEN Australia Holdings PTY Ltd.
  • Cellestis Limited
  • QIAGEN Sciences, LLC
Judges
  • Ronny Thomas
  • Jule Schumacher
  • Petri Rinkinen
  • Steen Wadskov-Hansen
Patents
  • EP2726883
CPC codes: Y02A90/10, G01N33/505, G01N33/56966, G01N33/68

Technology area: Biotech · Diagnostics Assay

Sector: Measurement & Testing

Outcome
Filed: Jun 10, 2025
First decided:
Language: English
Open on UPC Registry